glp-1 ai Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency Penn researchers use AI to
Description
Trilliant Health

Secondary outcomes included: monthly headache days, headache severity and monthly analgesia days, logMAR visual acuity measured using the Early Treatment Diabetic Retinopathy Study (ETDRS) charts

Among these products, one segment caught the attention of Drucker and colleagues

It remains to be determined how GLP-1 confers its kidney benefits, as the only GLP-1 receptor that has been identified has limited expression in the kidney (8)

Its not about money for them

Something that we see is that they help modulate the immune system
